10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

[x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

or

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from  to

Commission file number: 001-31321

NAUTILUS, INC.

(Exact name of Registrant as specified in its charter)

Washington	94-3002667
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

17750 S.E. 6th Way

Vancouver, Washington 98683

(Address of principal executive offices, including zip code)

(360) 859-2900

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  [x]    No  [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  [x]    No  [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer  [ ]            Accelerated filer  [x]        Non-accelerated filer  [ ]            Smaller reporting company  [ ]

(do not check if a smaller

         reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  [ ]    No  [x]

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

The number of shares outstanding of the registrant's common stock as of April 30, 2015 was 31,382,889 shares.

NAUTILUS, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015

	PART I
Item 1.	Condensed Financial Statements	2
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	21
Item 4.	Controls and Procedures	21
	PART II
Item 1.	Legal Proceedings	21
Item 1A.	Risk Factors	22
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	22
Item 6.	Exhibits	22
Signatures		23

1

PART I.    FINANCIAL INFORMATION

Item 1.     Condensed Financial Statements

NAUTILUS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited and in thousands)

	As of
	March 31, 2015			December 31, 2014
Assets
Cash and cash equivalents	$	30,693		$	45,206
Available-for-sale securities	51,390			26,984
Trade receivables, net of allowances of $36 and $108	16,816			26,260
Inventories	19,966			24,896
Prepaids and other current assets	5,342			6,987
Income taxes receivable	22			50
Deferred income tax assets	11,030			12,368
Total current assets	135,259			142,751
Property, plant and equipment, net	9,665			9,634
Goodwill	2,318			2,520
Other intangible assets, net	10,285			10,575
Long-term deferred income tax assets	4,797			9,546
Other assets	533			628
Total assets	$	162,857		$	175,654
Liabilities and Shareholders' Equity
Trade payables	$	26,829		$	47,574
Accrued liabilities	9,140			9,851
Warranty obligations, current portion	2,497			2,246
Total current liabilities	38,466			59,671
Income taxes payable, non-current	3,828			3,725
Other long-term liabilities	1,186			1,186
Total liabilities	43,480			64,582
Commitments and contingencies (Note 13)
Shareholders' equity:
Common stock - no par value, 75,000 shares authorized, 31,382 and 31,333 shares issued and outstanding	6,091			8,033
Retained earnings	114,079			103,347
Accumulated other comprehensive loss	(793		)	(308		)
Total shareholders' equity	119,377			111,072
Total liabilities and shareholders' equity	$	162,857		$	175,654

See accompanying Notes to Condensed Consolidated Financial Statements.

2

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited and in thousands, except per share amounts)

	Three Months Ended March 31,
	2015			2014
Net sales	$	96,239		$	71,903
Cost of sales	42,350			33,422
Gross profit	53,889			38,481
Operating expenses:
Selling and marketing	28,399			21,774
General and administrative	5,578			5,803
Research and development	2,307			1,903
Total operating expenses	36,284			29,480
Operating income	17,605			9,001
Other income (expense):
Interest income	44			8
Interest expense	(5		)	(7		)
Other, net	(116		)	(61		)
Total other income (expense), net	(77		)	(60		)
Income from continuing operations before income taxes	17,528			8,941
Income tax provision	6,669			3,193
Income from continuing operations	10,859			5,748
Discontinued operations:
Loss from discontinued operations before income taxes	(153		)	(512		)
Income tax benefit from discontinued operations	(26		)	(138		)
Loss from discontinued operations	(127		)	(374		)
Net income	$	10,732		$	5,374
Basic income per share from continuing operations	$	0.35		$	0.18
Basic loss per share from discontinued operations	—			(0.01		)
Basic net income per share(1)	$	0.34		$	0.17
Diluted income per share from continuing operations	$	0.34		$	0.18
Diluted loss per share from discontinued operations	—			(0.01		)
Diluted net income per share	$	0.34		$	0.17
Shares used in per share calculations:
Basic	31,396			31,172
Diluted	31,767			31,550
(1)May not add due to rounding.

See accompanying Notes to Condensed Consolidated Financial Statements.

3

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited and in thousands)

	Three Months Ended March 31,
	2015			2014
Net income	$	10,732		$	5,374
Other comprehensive loss:
Unrealized loss on marketable securities, net of income tax expense of $0 and $0	(1		)	(13		)
Foreign currency translation, net of income tax expense of $5 and $5	(484		)	(164		)
Comprehensive income	$	10,247		$	5,197

See accompanying Notes to Condensed Consolidated Financial Statements.

4

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited and in thousands)

	Three Months Ended March 31,
	2015			2014
Cash flows from operating activities:
Income from continuing operations	$	10,859		$	5,748
Loss from discontinued operations	(127		)	(374		)
Net income	10,732			5,374
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	910			865
Provision for (benefit from) allowance for doubtful accounts	(108		)	30
Inventory lower-of-cost-or-market adjustments	18			589
Stock-based compensation expense	301			265
(Gain) loss on asset dispositions	(2		)	1
Deferred income taxes, net of valuation allowance	6,102			2,321
Excess tax deficiency related to stock-based awards	2			102
Changes in operating assets and liabilities:
Trade receivables	9,719			11,752
Inventories	4,930			1,765
Prepaids and other current assets	1,763			2,617
Income taxes	27			356
Trade payables	(20,612		)	(9,830		)
Accrued liabilities, including warranty obligations	(298		)	(1,085		)
Net cash provided by operating activities	13,484			15,122
Cash flows from investing activities:
Purchases of available-for-sale securities	(30,440		)	(13,518		)
Proceeds from maturities of available-for-sale securities	3,680			—
Proceeds from sales of available-for-sale securities	2,354			—
Purchases of property, plant and equipment	(590		)	(521		)
Net cash used in investing activities	(24,996		)	(14,039		)
Cash flows from financing activities:
Proceeds from exercise of stock options	407			42
Payments for stock repurchases	(1,996		)	—
Tax payments related to stock award issuances	(652		)	—
Excess tax deficiency related to stock-based awards	(2		)	(102		)
Net cash used in financing activities	(2,243		)	(60		)
Effect of exchange rate changes on cash and cash equivalents	(758		)	33
Increase (decrease) in cash and cash equivalents	(14,513		)	1,056
Cash and cash equivalents:
Beginning of period	45,206			40,979
End of period	$	30,693		$	42,035
Supplemental disclosure of cash flow information:
Cash paid for interest	$	(6	)	$	(7	)
Cash paid for income taxes, net	(332		)	(95		)
Supplemental disclosure of non-cash investing activities:
Capital expenditures incurred but not yet paid	$	64		$	—

See accompanying Notes to Condensed Consolidated Financial Statements.

5

NAUTILUS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(1) GENERAL INFORMATION

Basis of Consolidation and Presentation

The accompanying condensed consolidated financial statements present the financial position, results of operations and cash flows of Nautilus, Inc. and its subsidiaries, all of which are wholly owned. Intercompany transactions and balances have been eliminated in consolidation.

The accompanying condensed consolidated financial statements have not been audited. We have condensed or omitted certain information and footnote disclosures normally included in financial statements presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the disclosures contained herein are adequate to make the information presented not misleading. However, these condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014 (the “2014 Form 10-K”).

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Further information regarding significant estimates can be found in our 2014 Form 10-K.

In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments necessary to present fairly our financial position as of March 31, 2015 and December 31, 2014, and our results of operations, comprehensive income and cash flows for the three months ended March 31, 2015 and 2014. Interim results are not necessarily indicative of results for a full year. Our revenues typically vary seasonally and this seasonality can have a significant effect on operating results, inventory levels and working capital needs.

Unless indicated otherwise, all information regarding our operating results pertain to our continuing operations.

New Accounting Pronouncements

ASU 2015-02

In February 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-02, “Consolidation (Topic 810).” ASU 2015-02 amends guidance regarding the consolidation of certain legal entities. ASU 2015-02 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015, with early adoption permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We do not expect the adoption of ASU 2015-02 to have any effect on our financial position, results of operations or cash flows.

ASU 2015-01

In January 2015, the FASB issued ASU 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20).” ASU 2015-01 simplifies income statement presentation by eliminating the concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015, with early adoption permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. The adoption of ASU 2015-01 will not have any effect on our financial position, results of operations or cash flows.

ASU 2014-12

In June 2014, the FASB issued ASU No. 2014-12, "Compensation - Stock Compensation (Topic 718)". ASU No. 2014-12 addresses accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. ASU 2014-12 indicates that, in such situations, the performance target should be treated as a performance condition and, accordingly, the performance target should not be reflected in estimating the grant-date fair value of the award. Instead, compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved. ASU 2014-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. We do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.

6

ASU 2014-09

In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers". ASU 2014-09 clarifies the principles for recognizing revenue and develops a common revenue standard for U.S. GAAP and the International Accounting Standards Board that:

• removes inconsistencies and weaknesses in revenue requirements;

• provides a more robust framework for addressing revenue issues;

• improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets;

• provides more useful information to users of financial statements through improved disclosure requirements; and

• simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer.

ASU 2014-09 is effective for annual and interim periods beginning on or after December 15, 2016. While we do not expect the adoption of ASU 2014-09 to have a material effect on our business, we are still evaluating any potential impact that adoption of

ASU 2014-09 may have on our financial position, results of operations or cash flows.

ASU 2014-08

In April 2014, the FASB issued ASU No. 2014-08, "Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity". ASU 2014-08 amends the definition for what types of asset disposals are to be considered discontinued operations, and amends the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 also enhances the convergence of the FASB’s and the International Accounting Standard Board’s reporting requirements for discontinued operations. ASU 2014-08 is effective for annual periods beginning on or after December 15, 2014, and interim periods within annual periods beginning on or after December 15, 2015. We do not expect the adoption of ASU 2014-08 to have a material effect on our financial position, results of operations or cash flows.

(2) DISCONTINUED OPERATIONS

There was no revenue related to discontinued operations for the three months endedMarch 31, 2015 or the year ended December 31, 2014. However, we continue to have legal and accounting expenses as we work with authorities on final deregistration of certain foreign entities and product liability expenses associated with product previously sold into the Commercial channel.

The following table summarizes liabilities for exit costs related to discontinued operations, included in Accrued Liabilities and Other Long-Term Liabilities in our Condensed Consolidated Balance Sheets (in thousands):

	Facilities Leases
Balance, December 31, 2014	$	573
Adjustments	—
Payments	(67		)
Balance, March 31, 2015	$	506

We expect the lease obligations to be paid out through 2016.

(3) FAIR VALUE MEASUREMENTS

Factors used in determining the fair value of financial assets and liabilities are summarized into three broad categories:

• Level 1 - observable inputs such as quoted prices (unadjusted) in active liquid markets for identical securities as of the reporting date;

• Level 2 - other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk; or observable market prices in markets with insufficient volume and/or infrequent transactions; and

• Level 3 - significant inputs that are generally unobservable inputs for which there is little or no market data available, including our own assumptions in determining fair value.

7

Assets measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014 were as follows (in thousands):

	March 31, 2015
	Level 1		Level 2		Level 3		Total
Cash Equivalents
Money market funds	$	10,630	$	—	$	—	$	10,630
Certificates of deposit(1)	—		245		—		245
Commercial paper	—		1,000		—		1,000
Corporate bonds	—		2,029		—		2,029
Variable-rate demand notes	—		—		—		—
Total Cash Equivalents	10,630		3,274		—		13,904
Available-for-Sale Securities
Certificates of deposit(1)	—		21,318		—		21,318
Commercial paper	—		4,996		—		4,996
Corporate bonds	—		25,076		—		25,076
Total Available-for-Sale Securities	—		51,390		—		51,390
Total assets measured at fair value	$	10,630	$	54,664	$	—	$	65,294

⁽¹⁾ All certificates of deposit are within current FDIC insurance limits.

	December 31, 2014
	Level 1		Level 2		Level 3		Total
Cash Equivalents
Money market funds	$	2,591	$	—	$	—	$	2,591
Certificates of deposit(1)	—		980		—		980
Commercial paper	—		12,497		—		12,497
Variable rate demand notes	—		8,000		—		8,000
Total Cash Equivalents	2,591		21,477		—		24,068
Available-for-Sale Securities
Certificates of deposit(1)	—		14,202		—		14,202
Corporate bonds	—		12,782		—		12,782
Total Available-for-Sale Securities	—		26,984		—		26,984
Total assets measured at fair value	$	2,591	$	48,461	$	—	$	51,052

⁽¹⁾ All certificates of deposit are within current FDIC insurance limits.

We did not have any liabilities measured at fair value on a recurring basis as of March 31, 2015 or December 31, 2014.

We recognize transfers between levels at the actual date of the event or change in circumstance that caused the transfer.  There were no transfers between levels during the three months ended March 31, 2015, nor for the year ended December 31, 2014.

We did not have any changes to our valuation techniques during the three months ended March 31, 2015.

We classify our marketable securities as available-for-sale and, accordingly, record them at fair value. Level 1 investments valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 investments valuations are obtained from inputs, other than quoted market prices in active markets, that are directly or indirectly observable

8

in the marketplace and quoted prices in markets with limited volume or infrequent transactions. The factors or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. Unrealized holding gains and losses are excluded from earnings and are reported net of tax in Comprehensive Income until realized.

We recognize or disclose the fair value of certain assets, such as non-financial assets, primarily Property, Plant and Equipment, Goodwill, Other Intangible Assets and certain other long-lived assets in connection with impairment evaluations. All of our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy. We did not perform any valuations on assets or liabilities that are valued at fair value on a nonrecurring basis during the first quarter of 2015. During the fourth quarter of 2014, we performed our annual Goodwill and indefinite-lived trade names impairment valuations effective as of October 1, 2014. During the three months ended March 31, 2015 and the year ended December 31, 2014, we did not record any other-than-temporary impairments on our financial assets required to be measured at fair value on a nonrecurring basis.

(4) INVENTORIES

Inventories are stated at the lower of cost or market, with cost determined based on the first-in, first-out method. We establish inventory allowances for excess, slow-moving and obsolete inventory based on inventory levels, expected product life and forecasted sales. Inventories are written down to market value based on historical demand, competitive factors, changes in technology and product lifecycles.

Inventories consisted of the following (in thousands):

	As of
	March 31, 2015		December 31, 2014
Finished goods	$	18,660	$	23,765
Parts and components	1,306		1,131
Total inventories	$	19,966	$	24,896

(5) PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following (in thousands):

	Estimated Useful Life (in years)			As of
				March 31, 2015			December 31, 2014
Automobiles	5			$	23		$	23
Leasehold improvements	5	to	20	2,159			2,144
Computer software and equipment	3	to	7	25,550			25,397
Machinery and equipment	3	to	5	6,724			6,709
Furniture and fixtures	5			1,104			1,108
Work in progress(1)	N/A			861			421
Total cost				36,421			35,802
Accumulated depreciation				(26,756		)	(26,168		)
Total property, plant and equipment, net				$	9,665		$	9,634

⁽¹⁾ Work in progress includes production tooling and internal use software development.

9

(6) GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

All goodwill is assigned to our Direct reporting segment. The rollforward of goodwill was as follows (in thousands):

Balance, January 1, 2014	$	2,740
Currency exchange rate adjustment	(220		)
Balance, December 31, 2014	2,520
Currency exchange rate adjustment	(202		)
Balance, March 31, 2015	$	2,318

Other Intangible Assets

Other intangible assets consisted of the following (in thousands):

	Estimated Useful Life (in years)			As of
				March 31, 2015			December 31, 2014
Other intangible assets:
Indefinite-lived trademarks	N/A			$	9,052		$	9,052
Patents	8	to	16	18,154			18,154
				27,206			27,206
Accumulated amortization - patents				(16,921		)	(16,631		)
Other intangible assets, net				$	10,285		$	10,575

Amortization expense was as follows (in thousands):

	Three Months Ended March 31,
	2015		2014
Patent amortization	$	290	$	510

Future amortization of patents is as follows (in thousands):

Remainder of 2015	$	538
2016	430
2017	143
2018	65
2019	35
Thereafter	22
	$	1,233

(7) ACCRUED LIABILITIES

Accrued liabilities consisted of the following (in thousands):

	As of
	March 31, 2015		December 31, 2014
Payroll and related liabilities	$	3,632	$	5,058
Other	5,508		4,793
Total accrued liabilities	$	9,140	$	9,851

10

(8) PRODUCT WARRANTIES

Our products carry limited, defined warranties for defects in materials or workmanship which, according to their terms, generally obligate us to pay the costs of supplying and shipping replacement parts to customers and, in certain instances, pay for labor and other costs to service products. Outstanding product warranty periods range from thirty days to, in limited circumstances, the lifetime of certain product components. We record a liability at the time of sale for the estimated costs of fulfilling future warranty claims. If necessary, we adjust the liability for specific warranty-related matters when they become known and are reasonably estimable. Estimated warranty expense is included in Cost of Sales, based on historical warranty claim experience and available product quality data. Warranty expense is affected by the performance of new products, significant manufacturing or design defects not discovered until after the product is delivered to the customer, product failure rates, and higher or lower than expected repair costs. If warranty expense differs from previous estimates, or if circumstances change such that the assumptions inherent in previous estimates are no longer valid, the amount of product warranty obligations is adjusted accordingly.

Changes in our product warranty obligations were as follows (in thousands):

	Three Months Ended March 31,
	2015			2014
Balance, beginning of period	$	2,246		$	1,638
Accruals	815			921
Payments	(564		)	(576		)
Balance, end of period	$	2,497		$	1,983

(9) ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Accumulated other comprehensive income (loss), net of applicable taxes, reported on our Condensed Consolidated Balance Sheets consists of unrealized holding losses on available-for-sale securities and foreign currency translation adjustments. The following tables set forth the changes in accumulated other comprehensive income (loss), net of tax (in thousands):

	Unrealized Loss on Available-for-Sale Securities			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Loss
Balance, December 31, 2014	$	(18	)	$	(290	)	$	(308	)
Current period other comprehensive loss	(1		)	(484		)	(485		)
Balance, March 31, 2015	$	(19	)	$	(774	)	$	(793	)

	Unrealized Loss on Available-for-Sale Securities			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2013	$	—		$	244		$	244
Current period other comprehensive loss	(13		)	(164		)	(177		)
Balance, March 31, 2014	$	(13	)	$	80		$	67

11

(10) INCOME PER SHARE

Basic per share amounts were computed using the weighted average number of common shares outstanding. Diluted per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method. The weighted average numbers of shares outstanding used to compute income per share were as follows (in thousands):

	Three Months Ended March 31,
	2015	2014
Shares used to calculate basic income per share	31,396	31,172
Dilutive effect of outstanding stock options, performance stock units and restricted stock units	371	378
Shares used to calculate diluted income per share	31,767	31,550

The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted income per share because, in the case of stock options, the average market price did not exceed the exercise price, and for the performance stock units, because these shares are subject to performance conditions that had not been met. These shares may be dilutive potential common shares in the future (in thousands):

	Three Months Ended March 31,
	2015	2014
Stock options	25	320
Performance stock units	163	84

(11) STOCK REPURCHASE PROGRAM

On November 3, 2014, our Board of Directors approved a stock repurchase program that authorized us to repurchase up to $15.0 million of our outstanding common stock from time to time over a period of 24 months. The repurchase program expires November 3, 2016. Share repurchases will be funded with existing cash balances and repurchased shares will be retired and returned to unissued authorized shares. During the first quarter of 2015, we repurchased 133,877 shares at an average price of $14.91per share for a total of$2.0 million, and, as of March 31, 2015,$13.0 millionremains available for future repurchases.

For additional information, see Issuer Purchases of Equity Securitiesat Part II, Item 2, "Unregistered Sales of Equity Securities and Use of Proceeds" in this Form 10-Q.

(12) SEGMENT AND ENTERPRISE-WIDE INFORMATION

We have two reportable segments - Direct and Retail. Contribution is the measure of profit or loss, defined as Net Sales less product costs and directly attributable expenses. Directly attributable expenses include Selling and Marketing expenses, General and Administrative expenses, and Research and Development expenses that are directly related to segment operations. Segment assets are those directly assigned to an operating segment's operations, primarily Accounts Receivable, Inventories, Goodwill and Other Intangible Assets. Unallocated assets primarily include Cash and Cash Equivalents, Available-for-Sale Securities, Prepaids and Other Current Assets, Deferred Income Tax Assets, Other Assets, shared information technology infrastructure, distribution centers and corporate headquarters. Capital expenditures directly attributable to the Direct and Retail segments were not significant in either period presented.

12

Following is summary information by reportable segment (in thousands):

	Three Months Ended March 31,
	2015			2014
Net sales:
Direct	$	74,057		$	50,735
Retail	21,290			20,103
Unallocated royalty income	892			1,065
Consolidated net sales	$	96,239		$	71,903
Contribution:
Direct	$	19,571		$	10,352
Retail	1,500			2,509
Unallocated royalty income	892			1,065
Consolidated contribution	$	21,963		$	13,926
Reconciliation of consolidated contribution to income from continuing operations:
Consolidated contribution	$	21,963		$	13,926
Amounts not directly related to segments:
Operating expenses	(4,358		)	(4,925		)
Other expense, net	(77		)	(60		)
Income tax expense	(6,669		)	(3,193		)
Income from continuing operations	$	10,859		$	5,748

There was no material change in the allocation of assets by segment during the first three months of 2015 and, accordingly, assets by segment are not presented.

For the three months ended March 31, 2015 and 2014, no customer represented 10.0% or more of total Net Sales.

(13) COMMITMENTS AND CONTINGENCIES

Guarantees, Commitments and Off-Balance Sheet Arrangements

As of March 31, 2015, we had approximately $0.6 million in standby letters of credit with certain vendors with expiration dates through April 2016.

We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of March 31, 2015, we had approximately $20.5 million in noncancelable market-based purchase obligations, primarily for inventory purchases expected to be received within the next twelve months. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses.

In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

The nature and terms of these indemnification obligations vary from contract to contract, and generally a maximum obligation is not stated within the agreements. We hold insurance policies that mitigate potential losses arising from certain types of indemnification obligations. Management does not deem these obligations to be significant to our financial position, results of operations or cash flows and, therefore, no related liabilities were recorded as of March 31, 2015.

13

Legal Matters

In 2004, we were sued in the Southern District of New York by BioSig Instruments, Inc. for alleged patent infringement in connection with our incorporation of heart rate monitors into certain cardio products. No significant activity in the litigation occurred until 2008. In 2012, the United States District Court granted summary judgment to us on grounds that BioSig’s patents

were invalid as a matter of law. BioSig appealed the grant of summary judgment and, in April 2013, the United States Court of Appeals for the Federal Circuit reversed the District Court’s decision on summary judgment and remanded the case to the District Court for further proceedings. On January 10, 2014, the U.S. Supreme Court granted our petition for a writ of certiorari to address the legal standard applied by the Federal Circuit in determining whether the patents may be valid under applicable law. The case was argued before the Supreme Court on April 28, 2014. By decision dated June 2, 2014, the Supreme Court unanimously reversed the Federal Circuit, holding that its standard of when a patent may be “indefinite” was incorrect and remanding to the Federal Circuit for reconsideration under the correct standard. The remand hearing in the Federal Circuit was held on October 29, 2014. By decision dated April 27, 2015, the same panel of the Federal Circuit affirmed its earlier reversal of the District Court’s decision. Unless we elect to petition for a rehearing en banc in the Federal Circuit or for further review in the United States Supreme Court the case will be returned to the District Court for further proceedings. We are currently evaluating these procedural options. We do not believe that our use of heart rate monitors utilized or purchased from third parties, and otherwise, infringes the BioSig patents.

In August 2014, we initiated an arbitration proceeding under a 1999 license agreement pursuant to which we had licensed certain rights relating to our TreadClimber^® products. We believe that our obligation to pay royalties under the license agreement ceased in the fourth quarter of 2013. The licensor disputes this and issued a notice under the contract claiming breach of the license agreement and asserting various remedies. We are seeking a declaratory ruling in the arbitration that we have performed all of our obligations under the license agreement, and that there is no continuing obligation for us to pay royalties. The licensor has asserted various counterclaims in the arbitration, including contract and intellectual property claims, and asserted various remedies, including termination of the license agreement. We replied to the counterclaim, denying the allegations and demanding remedies and asserting defenses. The arbitration is being administered by the American Arbitration Association and is in its preliminary stages. An arbitrator has been selected, however, a stay of the arbitration proceedings has been issued.

In addition to the matters described above, from time to time, we may be involved in various claims, lawsuits and other proceedings. These legal and tax proceedings involve uncertainty as to the eventual outcomes and losses which may be realized when one or more future events occur or fail to occur.

Litigation and jury verdicts are, to some degree, inherently unpredictable, and, although we have determined that a loss is not probable in connection with any current legal proceeding, it is reasonably possible that a loss may be incurred in connection with proceedings to which we are a party. Assessment of whether incurrence of a loss is probable, or a reasonable possibility, in connection with a particular proceeding, and estimation of the loss, or a range of loss, involves complex judgments and numerous uncertainties. Management is unable to estimate a range of reasonably possible losses related to litigation in its early stages, especially when the damages sought are indeterminate, or the legal and factual basis for the relevant claims have not been developed with specificity. As such, zero liability is recorded as of March 31, 2015.

We regularly monitor our estimated exposure to these contingencies and, as additional information becomes known, may change our estimates accordingly. We evaluate, on a quarterly basis, developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would make a loss probable or reasonably possible, and whether the amount of a probable or reasonably possible loss is estimable. Among other factors, we evaluate the advice of internal and external counsel, the outcomes from similar litigation, current status of the lawsuits (including settlement initiatives), legislative developments and other factors. Due to the numerous variables associated with these judgments and assumptions, both the precision and reliability of the resulting estimates of the related loss contingencies are subject to substantial uncertainties.

14

Item 2.     Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis is based upon our financial statements as of the dates and for the periods presented in this section. You should read this discussion and analysis in conjunction with the financial statements and notes thereto found in Part I, Item 1 of this Form 10-Q and our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014 (the “2014 Form 10-K”). All references to the first quarter and first three months of 2015 and 2014 mean the three-month periods ended March 31, 2015 and 2014, respectively. Unless the context otherwise requires, “Nautilus,” “we,” “us” and “our” refer to Nautilus, Inc. and its subsidiaries. Unless indicated otherwise, all information regarding our operating results pertains to our continuing operations.

Our results of operations may vary significantly from period-to-period. Our revenues typically fluctuate due to the seasonality of our industry, customer buying patterns, product innovation, the nature and level of competition for health and fitness products, our ability to procure products to meet customer demand, the level of spending on, and effectiveness of, our media and advertising programs and our ability to attract new customers and maintain existing sales relationships. In addition, our revenues are highly susceptible to economic factors, including, among other things, the overall condition of the economy and the availability of consumer credit in both the United States and Canada. Our profit margins may vary in response to the aforementioned factors and our ability to manage product costs. Profit margins may also be affected by fluctuations in the costs or availability of materials used to manufacture our products, product warranty costs, the cost of fuel, and changes in costs of other distribution or manufacturing-related services. Our operating profits or losses may also be affected by the efficiency and effectiveness of our organization. Historically, our operating expenses have been influenced by media costs to produce and distribute advertisements of our products on television, the Internet and other media, facility costs, operating costs of our information and communications systems, product supply chain management, customer support and new product development activities. In addition, our operating expenses have been affected from time-to-time by asset impairment charges, restructuring charges and other significant unusual or infrequent expenses.

As a result of the above and other factors, our period-to-period operating results may not be indicative of future performance. You should not place undue reliance on our operating results and should consider our prospects in light of the risks, expenses and difficulties typically encountered by us and other companies, both within and outside our industry. We may not be able to successfully address these risks and difficulties and, consequently, we cannot assure you of any future growth or profitability. For more information, see our discussion of Risk Factors located at Part I, Item 1A of our 2014 Form 10-K.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "plan," "expect," "aim," "believe," "project," "intend," "estimate," "will," "should," "could," and other terms of similar meaning typically identify forward-looking statements. The forward-looking statements in this report include, without limitation: our prospects, resources or capabilities; current or future financial trends; future operating results; future plans for introduction of new products; anticipated demand for our new and existing products; maintenance of appropriate inventory levels; growth in revenues and profits; leverage of operating expenses; future revenues from our licensing initiative; results of increased media investment in the Direct segment; continued improvement in operating margins; expectations for increased Research and Development expenses; the amount expected to be spent on software and equipment in 2015; fluctuations in Net Sales due to seasonality; and our ability to continue to fund our operating and capital needs for the following twelve-month period. Forward-looking statements also include any statements related to our expectations regarding future business and financial performance or conditions, anticipated sales growth across markets, distribution channels and product categories, expenses and gross margins, profits or losses, losses from discontinued operations, settlements of warranty obligations, the anticipated outcome of litigation to which we are a party, new product introductions, financing and working capital requirements and resources. These forward-looking statements, and others we make from time-to-time, are subject to a number of risks and uncertainties. Many factors could cause actual results to differ materially from those projected in forward-looking statements, including the risks described in Part I, Item 1A, "Risk Factors," in our 2014 Form 10-K as supplemented or modified in our quarterly reports on Form 10-Q. We do not undertake any duty to update forward-looking statements after the date they are made or conform them to actual results or to changes in circumstances or expectations.

Overview

We are committed to providing innovative, quality solutions to help people achieve a fit and healthy lifestyle. Our principal business activities include designing, developing, sourcing and marketing high-quality cardio and strength fitness products and related accessories for consumer use, primarily in the United States and Canada. Our products are sold under some of the most-recognized brand names in the fitness industry: Nautilus^®, Bowflex^®, Schwinn^® and Universal^®.

15

We market our products through two distinct distribution channels, Direct and Retail, which we consider to be separate business segments. Our Direct business offers products directly to consumers through television advertising, catalogs and the Internet. Our Retail business offers our products through a network of independent retail companies with stores and websites located in the United States and internationally. We also derive a portion of our revenue from the licensing of our brands and intellectual property.

Net Sales for the first three months of 2015 were $96.2 million, an increase of $24.3 million, or 33.8%, as compared to Net Sales of $71.9 million for the first three months of 2014. Net sales of our Direct segment increased$23.3 million, or 46.0%, in the first three months of 2015, compared to the first three months of 2014, primarily due to increased consumer demand for our cardio products, especially the recently released Bowflex Max Trainer^®, which started shipping in January 2014. Net sales of our Retail segment increased by $1.2 million, or 5.9%, in the first three months of 2015, compared to the first three months of 2014, primarily due to favorable retailer sell-through of our new lineup of cardio products.

Gross Profit for the first three months of 2015 was $53.9 million, or 56.0% of sales, an increase of $15.4 million, or 40.0%, as compared to Gross Profit of $38.5 million, or 53.5% of sales, for the first three months of 2014. The increase in Gross Profit dollars was primarily due to the increase in Net Sales, while the increase in gross profit margin percentage was due to shift in channel mix to the Direct segment.

Operating Expenses for the first three months of 2015 were $36.3 million, an increase of $6.8 million, or 23.1%, as compared to Operating Expenses of $29.5 million for the first three months of 2014. The growth in Operating Expenses was primarily related to increases in Selling and Marketing expenses.

Operating Income for the first three months of 2015 was $17.6 million, an increase of $8.6 million, or 95.6%, as compared to Operating Income of $9.0 million for the first three months of 2014. The improvement in our operating results for the first three months of 2015 compared to the first three months of 2014 was driven primarily by higher Net Sales and improved Gross Profit margins coupled with leveraging operating expense over higher revenues.

Income from Continuing Operations was $10.9 million for the first three months of 2015, or $0.34 per diluted share, compared to Income From Continuing Operations of $5.7 million, or $0.18 per diluted share, for the first three months of 2014. The effective tax rates for the first three months of 2015 and 2014 were 38.0% and 35.7%, respectively.

Net income for the first three months of 2015 was $10.7 million, compared to net income of $5.4 million for the first three months of 2014. Net income per diluted share was $0.34 for the first three months of 2015, compared to $0.17 per diluted share for the first three months of 2014.

Discontinued Operations

Results from discontinued operations relate to the disposal of our former Commercial business, which was completed in April 2011. We reached substantial completion of asset liquidation at December 31, 2012. Although there was no revenue related to the Commercial business in either the 2015 or 2014 periods, we continue to have legal and accounting expenses as we work with authorities on final deregistration of each entity, and product liability and other legal expenses associated with product previously sold into the Commercial channel.

16

RESULTS OF OPERATIONS

Results of operations information was as follows (in thousands):

	Three Months Ended March 31,						Change
	2015			2014			$			%
Net sales	$	96,239		$	71,903		$	24,336		33.8	%
Cost of sales	42,350			33,422			8,928			26.7	%
Gross profit	53,889			38,481			15,408			40.0	%
Operating expenses:
Selling and marketing	28,399			21,774			6,625			30.4	%
General and administrative	5,578			5,803			(225		)	(3.9	)%
Research and development	2,307			1,903			404			21.2	%
Total operating expenses	36,284			29,480			6,804			23.1	%
Operating income	17,605			9,001			8,604			95.6	%
Other income (expense):
Interest income	44			8			36
Interest expense	(5		)	(7		)	2
Other	(116		)	(61		)	(55		)
Total other income (expense), net	(77		)	(60		)	(17		)
Income from continuing operations before income taxes	17,528			8,941			8,587
Income tax expense	6,669			3,193			3,476
Income from continuing operations	10,859			5,748			5,111
Loss from discontinued operations, net of income taxes	(127		)	(374		)	247
Net income	$	10,732		$	5,374		$	5,358

Results of operations information by segment was as follows (in thousands):

	Three Months Ended March 31,						Change
	2015			2014			$				%
Net sales:
Direct	$	74,057		$	50,735		$	23,322			46.0	%
Retail	21,290			20,103			1,187				5.9	%
Royalty income	892			1,065			(173		)		(16.2	)%
	$	96,239		$	71,903		$	24,336			33.8	%
Cost of sales:
Direct	$	25,747		$	18,417		$	7,330			39.8	%
Retail	16,603			15,005			1,598				10.6	%
Royalty income	—			—			—				—	%
	$	42,350		$	33,422		$	8,928			26.7	%
Gross profit:
Direct	$	48,310		$	32,318		$	15,992			49.5	%
Retail	4,687			5,098			(411		)		(8.1	)%
Royalty income	892			1,065			(173		)		(16.2	)%
	$	53,889		$	38,481		$	15,408			40.0	%
Gross margin:
Direct	65.2		%	63.7		%	150			basis points
Retail	22.0		%	25.4		%	(340		)	basis points

17

The following table compares the Net Sales of our major product lines within each business segment (in thousands):

	Three Months Ended March 31,				Change
	2015		2014		$			%
Direct net sales:
Cardio products(1)	$	70,034	$	45,863	$	24,171		52.7	%
Strength products(2)	4,023		4,872		(849		)	(17.4	)%
	74,057		50,735		23,322			46.0	%
Retail net sales:
Cardio products(1)	13,886		12,376		1,510			12.2	%
Strength products(2)	7,404		7,727		(323		)	(4.2	)%
	21,290		20,103		1,187			5.9	%
Royalty income	892		1,065		(173		)	(16.2	)%
	$	96,239	$	71,903	$	24,336		33.8	%
(1)   Cardio products include: TreadClimber®, Max Trainer®, treadmills, exercise bikes, ellipticals, Bowflex Boost®, Bowflex BodyTM and DVDs.
(2)   Strength products include: home gyms, selectorized dumbbells, kettlebell weights, UpperCut™ and accessories.

Direct

The 46.0%increase in Direct Net Sales for the first three months of 2015 compared to the same period of 2014 was primarily related to the increase in sales of our cardio products, especially the Bowflex Max Trainer^®, which started shipping in early 2014.

The increase in Direct Net Sales of cardio products in the first three months of 2015 compared to the same period of 2014 was partially offset by a decline in Direct Net Sales of strength products, primarily due to lower sales of rod-based home gyms. The decline was attributable, in part, to the reduction of advertising for these products over time, as management determined that television advertising spending on this mature product category was generating suboptimal returns. We continue to market and sell rod-based home gyms within the Direct segment through more cost-efficient online media. Additionally, a portion of our sales of strength products have shifted to the Retail segment.

Combined consumer credit approvals by our primary and secondary U.S. third-party financing providers for the three-month period ended March 31, 2015 increased to 44.5%, compared to 41.3% in the same period of 2014. We attribute the increase to sales of the Bowflex Max Trainer^®, which has attracted consumers with better credit scores, and our media strategy focused on driving quality consumer leads.

The increase in Cost of Sales of our Direct business in the three-month period of 2015 compared to the same period of 2014 was almost entirely related to the growth in Direct Net Sales as discussed above.

The 150 basis point increase in the gross margin of our Direct business for the three-month period of 2015 compared to the same period of 2014 was primarily due to the non-recurrence of inventory write-downs for discontinued product required in the prior year.

Retail

The 5.9%increase in Retail Net Sales in the three-month period of 2015 compared to the same period of 2014 was driven by increased sales of the lineup of cardio products launched in late 2013 and Fall 2014.

The increase in Retail Cost of Sales for the three-month period of 2015 compared to the same period of 2014 was due to the increase in Retail Net Sales.

The 340 basis point decrease in Retail gross margin in the three-month period of 2015 compared to the same period of 2014 was primarily due to unfavorable customer and product mix, and higher distribution related costs.

18

Selling and Marketing

Dollars in thousands	Three Months Ended March 31,		Change
	2015	2014	$	%
Selling and Marketing	$28,399	$21,774	$6,625	30.4%
As % of Net Sales	29.5%	30.3%

The increase in Selling and Marketing expense in the three-month period of 2015 compared to the same period of 2014 was primarily related to an increase in media advertising of $3.6 million as discussed below and an increase in incremental variable sales expense of $2.8 million, primarily financing fees, related to the increase in Net Sales.

The decrease as a percentage of Net Sales in the three-month period of 2015 compared to the same period of 2014 was primarily due to the increases in Net Sales.

Media advertising expense of our Direct business is the largest component of Selling and Marketing and was as follows:

Dollars in thousands	Three Months Ended March 31,		Change
	2015	2014	$	%
Media advertising	$14,242	$10,667	$3,575	33.5%

The increase in media advertising in the three-month period of 2015 compared to the same period of 2014 was primarily to drive incremental sales in the Direct business.

General and Administrative

Dollars in thousands	Three Months Ended March 31,		Change
	2015	2014	$	%
General and Administrative	$5,578	$5,803	$(225)	(3.9)%
As % of Net Sales	5.8%	8.1%

The decrease in General and Administrative in the three-month period of 2015 compared to the same period of 2014 was primarily due to lower spending on legal expenses for patent enforcement cases and intellectual property registration fees.

The decrease as a percentage of Net Sales in the three-month period of 2015 compared to the same period of 2014 was primarily due to the increase in Net Sales, coupled with lower spending.

Research and Development

Dollars in thousands	Three Months Ended March 31,		Change
	2015	2014	$	%
Research and Development	$2,307	$1,903	$404	21.2%
As % of Net Sales	2.4%	2.6%

The increase in Research and Development in the three-month period of 2015 compared to the same period of 2014 was primarily due to our continued investment in resources required to innovate and broaden our product portfolio.

Other Income (Expense)

Other Income (Expense) primarily relates to the effect of exchange rate fluctuations between the U.S. and Canada.

19

Income Tax Provision

Dollars in thousands	Three Months Ended March 31,		Change
	2015	2014	$	%
Income Tax Provision	$6,669	$3,193	$3,476	108.9%
Effective tax rate	38.0%	35.7%

Income tax provision for the first three months of 2015 from continuing operations was based on a 38.0% effective tax rate and primarily related to our profitable U.S. and Canadian operations. The decreased effective tax rate of 35.7% for the first three months of 2014 was mainly driven by a certain U.S. tax credit benefit recognized during the first quarter of 2014.

LIQUIDITY AND CAPITAL RESOURCES

As of March 31, 2015, we had total cash and investments of $82.1 million compared to $72.2 million as of December 31, 2014. Cash provided by operating activities was $13.5 million for the three months endedMarch 31, 2015, compared to $15.1 million for the three months endedMarch 31, 2014. We expect our Cash, Cash Equivalents and Available-for-Sale Securities at March 31, 2015, along with cash expected to be generated from operations, to be sufficient to fund our operating and capital requirements for at least twelve months from March 31, 2015.

The decrease in cash flows from operating activities for the three months endedMarch 31, 2015 as compared to the same period of 2014 was primarily due to changes in our operating assets and liabilities as discussed below, partially offset by improved operating performance.

Trade Receivables decreased$9.4 million to $16.8 million as of March 31, 2015, compared to $26.3 million as of December 31, 2014, due to seasonally lower Net Sales in the Retail business. Days sales outstanding ("DSO") at March 31, 2015 were 13.9 days compared to 17.6 days as of December 31, 2014 and 17.9 days as of March 31, 2014. The decrease in DSO at March 31, 2015 compared to December 31, 2014 and March 31, 2014 was due to a greater mix of of Direct revenue. Direct sales are generally collected by credit card or funded by third party financing partners, resulting in cash receipt within a few days after product shipment.

Prepaid and Other Current Assets decreased$1.6 million to $5.3 million as of March 31, 2015 compared to $7.0 million as of December 31, 2014, primarily due to seasonality of the business and reduction of royalties receivable of $1.3 million. Prepaid marketing as of March 31, 2015 compared to December 31, 2014 also decreased by $0.4 million primarily due to recognition of catalog related costs.

Inventories decreased$4.9 million to $20.0 million as of March 31, 2015, compared to $24.9 million as of December 31, 2014, due to seasonality of the business and lower in-transit inventory resulting from the resolution of the West Coast port labor dispute. Inventories as of March 31, 2015 compared to March 31, 2014increased by $6.5 million, primarily due to higher revenues, new product introductions, and the addition of a new distribution center.

Deferred income tax assets decreased$6.1 million to $15.8 million as of March 31, 2015 compared to $21.9 million as of December 31, 2014, primarily due to the utilization of net operating loss carryforwards from prior periods.

Trade Payables decreased$20.7 million to $26.8 million as of March 31, 2015, compared to $47.6 million as of December 31, 2014, primarily due to seasonality of the business.

Cash used in investing activities of $25.0 million for the first three months of 2015 was primarily related to the purchase of $30.4 million of marketable securities, offset by maturities and sales of marketable securities of $3.7 million and $2.4 million, respectively, during the period. Additionally, $0.6 million in capital expenditures was incurred during the period primarily for new software and information technology equipment. We anticipate spending between $6.0 million to $7.0 million in 2015 for software, equipment, leasehold improvements and product tooling.

Cash used in financing activities of $2.2 million for the first three months of 2015 was primarily related to the share buyback program effected of $2.0 million.

20

Financing Arrangements

On December 5, 2014, we entered into a Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A. ("Chase Bank") that provides for a $20.0 million maximum revolving secured credit line. The line of credit is available through December 5, 2017 for working capital, letters of credit and general corporate purposes. Borrowing availability under the Credit Agreement is subject to our compliance with certain financial and operating covenants at the time borrowings are requested. Letters of credit under the Credit Agreement are treated as a reduction of the available borrowing amount and are subject to covenant testing.

The interest rate applicable to each advance under the Credit Agreement is based on either Chase Bank's floating prime rate or adjusted LIBOR, plus an applicable margin. Our borrowing rate was 1.18% as of March 31, 2015. The Credit Agreement contains customary covenants, including minimum fixed charge coverage ratio and asset coverage ratio, and limitations on capital expenditures, mergers and acquisitions, indebtedness, liens, dispositions, dividends and investments. Borrowings under the Credit Agreement are collateralized by substantially all of our assets pursuant to a continuing security agreement. The Credit Agreement also contains customary events of default. Upon an event of default, the lender may terminate its credit line commitment, accelerate all outstanding obligations and exercise its remedies under the continuing security agreement.

As of March 31, 2015, we had no outstanding borrowings and $0.6 million in letters of credit issued under the Credit Agreement with expiration dates through April 2016. As of March 31, 2015, we were in compliance with the financial covenants of the Credit Agreement and approximately $19.4 million was available for borrowing.

Commitments and Contingencies

For a description of our commitments and contingencies, refer to Note 13 to our Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q.

Off-Balance Sheet Arrangements

In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from our use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

The nature and terms of these indemnifications vary from contract to contract, and generally a maximum obligation is not stated. We hold insurance policies that mitigate potential losses arising from certain types of indemnifications. Because we are unable to estimate our potential obligation, and because management does not expect these obligations to have a material adverse effect on our consolidated financial position, results of operations or cash flows, no liabilities are recorded at March 31, 2015.

Stock Repurchase Program

On November 3, 2014, our Board of Directors approved a stock repurchase program that authorized us to repurchase up to $15.0 million of our outstanding common stock from time to time over a period of 24 months. The repurchase program expires November 3, 2016. Share repurchases will be funded with existing cash balances and repurchased shares will be retired and returned to unissued authorized shares. During the first quarter of 2015, we repurchased 133,877 shares at an average price of $14.91per share for a total of$2.0 million, and, as of March 31, 2015,$13.0 millionremains available for future repurchases.

For additional information, see Issuer Purchases of Equity Securitiesat Part II, Item 2, "Unregistered Sales of Equity Securities and Use of Proceeds" in this Form 10-Q.

SEASONALITY

We expect our sales from fitness equipment products to vary seasonally. Sales are typically strongest in the first and fourth quarters, followed by the third quarter, and are generally weakest in the second quarter. We believe that, during the spring and summer months, consumers tend to be involved in outdoor activities, including outdoor exercise, which impacts sales of indoor fitness equipment. This seasonality can have a significant effect on our inventory levels, working capital needs and resource utilization.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our critical accounting policies have not changed from those discussed in our 2014 Form 10-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in our reported market risks or risk management policies since the filing of our 2014 Form 10-K, which was filed with the Securities and Exchange Commission on February 26, 2015.

Item 4.     Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15 of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a- 15(e) and Rule 15d-15(e) under the Exchange Act). Based upon their evaluation of these disclosure controls and procedures, our management, including the Chief Executive Officer and Chief Financial Officer, have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the three months ended March 31, 2015, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II.    OTHER INFORMATION

Item 1. Legal Proceedings

In 2004, we were sued in the Southern District of New York by BioSig Instruments, Inc. for alleged patent infringement in connection with our incorporation of heart rate monitors into certain cardio products. No significant activity in the litigation occurred until 2008. In 2012, the United States District Court granted summary judgment to us on grounds that BioSig’s patents

were invalid as a matter of law. BioSig appealed the grant of summary judgment and, in April 2013, the United States Court of Appeals for the Federal Circuit reversed the District Court’s decision on summary judgment and remanded the case to the District Court for further proceedings. On January 10, 2014, the U.S. Supreme Court granted our petition for a writ of certiorari to address the legal standard applied by the Federal Circuit in determining whether the patents may be valid under applicable law. The case was argued before the Supreme Court on April 28, 2014. By decision dated June 2, 2014, the Supreme Court unanimously reversed the Federal Circuit, holding that its standard of when a patent may be “indefinite” was incorrect and remanding to the Federal Circuit for reconsideration under the correct standard. The remand hearing in the Federal Circuit was held on October 29, 2014. By decision dated April 27, 2015, the same panel of the Federal Circuit affirmed its earlier reversal of the District Court’s decision. Unless we elect to petition for a rehearing en banc in the Federal Circuit or for further review in the United States Supreme Court the case will be returned to the District Court for further proceedings. We are currently evaluating these procedural options. We do not believe that our use of heart rate monitors utilized or purchased from third parties, and otherwise, infringes the BioSig patents.

In August 2014, we initiated an arbitration proceeding under a 1999 license agreement pursuant to which we had licensed certain rights relating to our TreadClimber^® products. We believe that our obligation to pay royalties under the license agreement ceased in the fourth quarter of 2013. The licensor disputes this and issued a notice under the contract claiming breach of the license agreement and asserting various remedies. We are seeking a declaratory ruling in the arbitration that we have performed all of our obligations under the license agreement, and that there is no continuing obligation for us to pay royalties. The licensor has asserted various counterclaims in the arbitration, including contract and intellectual property claims, and asserted various remedies, including termination of the license agreement. We replied to the counterclaim, denying the allegations and demanding remedies and asserting defenses. The arbitration is being administered by the American Arbitration Association and is in its preliminary stages. An arbitrator has been selected, however, a stay of the arbitration proceedings has been issued.

In addition to the matters described above, from time to time we are subject to litigation, claims and assessments that arise in the ordinary course of business, including disputes that may arise from intellectual property related matters. Management believes that any liability resulting from such additional matters will not have a material adverse effect on our financial position, results of operations or cash flows.

21

Item 1A.    Risk Factors

We operate in an environment that involves a number of risks and uncertainties. The risks and uncertainties described in our 2014 Form 10-K are not the only risks and uncertainties that we face. Additional risks and uncertainties that presently are not considered material or are not known to us, and therefore are not mentioned herein, may impair our business operations. If any of the risks described in our 2014 Form 10-K actually occur, our business, operating results and financial position could be adversely affected. There has not been a material change to the risk factors as set forth in our 2014 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

The following table provides information about our repurchases of our equity securities during the first quarter ended March 31, 2015:

Period			(a) Total Number of Shares (or Units) Purchased	(b) Average Price Paid per Share (or Unit)	(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs (3)	(d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs(3)
January 1 - January 31	(1	)	2,634	$14.24	—	$15,000,000
February 1 - February 28	(1	)	40,255	$15.27	—	$15,000,000
March 1 - March 31	(2	)	136,183	$14.92	133,877	$13,004,018
Total			179,072	$14.98	133,877	$13,004,018
(1)  Consists of shares withheld from the vesting portions of stock unit awards to our named executive officers to satisfy the executive's tax withholding obligation incident to such vesting.
(2)  Includes 2,306 shares withheld from the vesting portion of a stock unit award granted to Bruce M. Cazenave, our Chief Executive Officer. We will withhold from each monthly vesting portion of the award the number of shares sufficient to satisfy Mr. Cazenave's tax withholding obligation incident to such vesting, unless Mr. Cazenave should first elect to satisfy the tax obligation by cash payment to us.
(3)  On November 3, 2014, our Board of Directors approved a stock repurchase program that authorizes us to repurchase up to $15.0 million of our outstanding common stock from time to time over a period of 24 months. The repurchase program expires November 3, 2016.

Item 6.    Exhibits

The following exhibits are filed herewith and this list is intended to constitute the exhibit index:

Exhibit No.	Description
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
32.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following financial statements from Nautilus, Inc.'s quarterly report on Form 10-Q for the three months ended March 31, 2015 formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets (unaudited), (ii) Condensed Consolidated Statements of Operations (unaudited), (iii) Condensed Consolidated Statements of Comprehensive Income (unaudited), (iv) Condensed Consolidated Statements of Cash Flows (unaudited) and (v) Notes to Condensed Consolidated Financial Statements (unaudited).

22

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	NAUTILUS, INC.
May 7, 2015	By:	/S/    Bruce M. Cazenave
Date		Bruce M. Cazenave
		Chief Executive Officer (Principal Executive Officer)

	NAUTILUS, INC.
May 7, 2015	By:	/S/    Sidharth Nayar
Date		Sidharth Nayar
		Chief Financial Officer (Principal Financial and Accounting Officer)

23

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Bruce M. Cazenave, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Nautilus, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

May 7, 2015	By:	/s/ Bruce M. Cazenave
Date		Bruce M. Cazenave
		Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Sidharth Nayar, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Nautilus, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

May 7, 2015	By:	/s/ Sidharth Nayar
Date		Sidharth Nayar
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of Nautilus, Inc., a Washington corporation (the “Company”), do hereby certify that:

To our knowledge, the Quarterly Report on Form 10-Q for the period ended March 31, 2015 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 7, 2015	By:	/s/ Bruce M. Cazenave
Date		Bruce M. Cazenave
		Chief Executive Officer (Principal Executive Officer)

May 7, 2015	By:	/s/ Sidharth Nayar
Date		Sidharth Nayar
		Chief Financial Officer (Principal Financial and Accounting Officer)

XML

Accrued Liabilities (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Payables and Accruals [Abstract]
Payroll and related liabilities	$ 3,632	$ 5,058
Other	5,508	4,793
Total accrued liabilities	$ 9,140	$ 9,851

XML

Inventories (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Inventory Disclosure [Abstract]
Finished goods	$ 18,660	$ 23,765
Parts and components	1,306	1,131
Total inventories	$ 19,966	$ 24,896

XML

Goodwill and Other Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill and Other Intangible Assets

The rollforward of goodwill was as follows (in thousands):

Balance, January 1, 2014	$	2,740
Currency exchange rate adjustment	(220		)
Balance, December 31, 2014	2,520
Currency exchange rate adjustment	(202		)
Balance, March 31, 2015	$	2,318

Other Intangible Assets

Other intangible assets consisted of the following (in thousands):

	Estimated Useful Life (in years)			As of
				March 31, 2015			December 31, 2014
Other intangible assets:
Indefinite-lived trademarks	N/A			$	9,052		$	9,052
Patents	8	to	16	18,154			18,154
				27,206			27,206
Accumulated amortization - patents				(16,921		)	(16,631		)
Other intangible assets, net				$	10,285		$	10,575

Amortization Expense

Amortization expense was as follows (in thousands):

	Three Months Ended March 31,
	2015		2014
Patent amortization	$	290	$	510

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Future amortization of patents is as follows (in thousands):

Remainder of 2015	$	538
2016	430
2017	143
2018	65
2019	35
Thereafter	22
	$	1,233

XML

Income Per Share (Details) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income per share:
Shares used to calculate basic income per share	31,396	31,172
Dilutive effect of outstanding stock options, performance stock units and restricted stock units	371	378
Shares used to calculate diluted income per share	31,767	31,550
Stock options
Income per share:
Anti-dilutive securities excluded from computation of diluted income per share	25	320
Performance stock units
Income per share:
Anti-dilutive securities excluded from computation of diluted income per share	163	84

XML

Goodwill and Other Intangible Assets Patent amortization (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Patent amortization	$ 290	$ 510

XML

Discontinued Operations

3 Months Ended

Mar. 31, 2015

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

DISCONTINUED OPERATIONS

There was no revenue related to discontinued operations for the three months endedMarch 31, 2015 or the year ended December 31, 2014. However, we continue to have legal and accounting expenses as we work with authorities on final deregistration of certain foreign entities and product liability expenses associated with product previously sold into the Commercial channel.

The following table summarizes liabilities for exit costs related to discontinued operations, included in Accrued Liabilities and Other Long-Term Liabilities in our Condensed Consolidated Balance Sheets (in thousands):

	Facilities Leases
Balance, December 31, 2014	$	573
Adjustments	—
Payments	(67		)
Balance, March 31, 2015	$	506

We expect the lease obligations to be paid out through 2016.

XML

Stock Repurchase Program (Details) (Common Stock, USD $)	0 Months Ended	3 Months Ended
	Nov. 03, 2014	Mar. 31, 2015	Nov. 03, 2014
Common Stock
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, authorized amount	$ 15,000,000		$ 15,000,000
Stock repurchase program, period in force	24 months
Shares repurchased (shares)		133,877.000
Average cost per share repurchased		$ 14.91
Shares repurchased (value)		2,000,000
Remaining authorized repurchase amount		$ 13,000,000

XML

Income Per Share (Tables)

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Schedule of Weighted Average Number of Shares Outstanding Used to Compute Income Per Share

The weighted average numbers of shares outstanding used to compute income per share were as follows (in thousands):

	Three Months Ended March 31,
	2015	2014
Shares used to calculate basic income per share	31,396	31,172
Dilutive effect of outstanding stock options, performance stock units and restricted stock units	371	378
Shares used to calculate diluted income per share	31,767	31,550

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted income per share because, in the case of stock options, the average market price did not exceed the exercise price, and for the performance stock units, because these shares are subject to performance conditions that had not been met. These shares may be dilutive potential common shares in the future (in thousands):

	Three Months Ended March 31,
	2015	2014
Stock options	25	320
Performance stock units	163	84

XML

Accumulated Other Comprehensive Income (Loss) (Tables)

3 Months Ended

Mar. 31, 2015

Equity [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The following tables set forth the changes in accumulated other comprehensive income (loss), net of tax (in thousands):

	Unrealized Loss on Available-for-Sale Securities			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Loss
Balance, December 31, 2014	$	(18	)	$	(290	)	$	(308	)
Current period other comprehensive loss	(1		)	(484		)	(485		)
Balance, March 31, 2015	$	(19	)	$	(774	)	$	(793	)

	Unrealized Loss on Available-for-Sale Securities			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2013	$	—		$	244		$	244
Current period other comprehensive loss	(13		)	(164		)	(177		)
Balance, March 31, 2014	$	(13	)	$	80		$	67

XML

Segment and Enterprise-wide Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015 segment	Mar. 31, 2014
Segment Reporting Information [Line Items]
Number of reportable segments	2
Net sales	$ 96,239	$ 71,903
Contribution	21,963	13,926
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Operating expenses	(36,284)	(29,480)
Income tax expense	(6,669)	(3,193)
Income from continuing operations	10,859	5,748
Direct
Segment Reporting Information [Line Items]
Net sales	74,057	50,735
Contribution	19,571	10,352
Retail
Segment Reporting Information [Line Items]
Net sales	21,290	20,103
Contribution	1,500	2,509
Unallocated royalty income
Segment Reporting Information [Line Items]
Net sales	892	1,065
Contribution	892	1,065
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Operating expenses	(4,358)	(4,925)
Other expense, net	(77)	(60)
Income tax expense	(6,669)	(3,193)
Income from continuing operations	$ 10,859	$ 5,748

XML

Segment and Enterprise-wide Information (Tables)

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Summary Information by Reportable Segments

Following is summary information by reportable segment (in thousands):

	Three Months Ended March 31,
	2015			2014
Net sales:
Direct	$	74,057		$	50,735
Retail	21,290			20,103
Unallocated royalty income	892			1,065
Consolidated net sales	$	96,239		$	71,903
Contribution:
Direct	$	19,571		$	10,352
Retail	1,500			2,509
Unallocated royalty income	892			1,065
Consolidated contribution	$	21,963		$	13,926
Reconciliation of consolidated contribution to income from continuing operations:
Consolidated contribution	$	21,963		$	13,926
Amounts not directly related to segments:
Operating expenses	(4,358		)	(4,925		)
Other expense, net	(77		)	(60		)
Income tax expense	(6,669		)	(3,193		)
Income from continuing operations	$	10,859		$	5,748

XML

Discontinued Operations (Details) (Facilities Leases, USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015
Facilities Leases
Restructuring Reserve [Roll Forward]
Balance, December 31, 2014	$ 573
Adjustments	0
Payments	(67)
Balance, March 31, 2015	$ 506

XML

General Information

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

General Information

GENERAL INFORMATION

Basis of Consolidation and Presentation

The accompanying condensed consolidated financial statements present the financial position, results of operations and cash flows of Nautilus, Inc. and its subsidiaries, all of which are wholly owned. Intercompany transactions and balances have been eliminated in consolidation.

The accompanying condensed consolidated financial statements have not been audited. We have condensed or omitted certain information and footnote disclosures normally included in financial statements presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the disclosures contained herein are adequate to make the information presented not misleading. However, these condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014 (the “2014 Form 10-K”).

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Further information regarding significant estimates can be found in our 2014 Form 10-K.

In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments necessary to present fairly our financial position as of March 31, 2015 and December 31, 2014, and our results of operations, comprehensive income and cash flows for the three months ended March 31, 2015 and 2014. Interim results are not necessarily indicative of results for a full year. Our revenues typically vary seasonally and this seasonality can have a significant effect on operating results, inventory levels and working capital needs.

Unless indicated otherwise, all information regarding our operating results pertain to our continuing operations.

New Accounting Pronouncements

ASU 2015-02

In February 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-02, “Consolidation (Topic 810).” ASU 2015-02 amends guidance regarding the consolidation of certain legal entities. ASU 2015-02 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015, with early adoption permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We do not expect the adoption of ASU 2015-02 to have any effect on our financial position, results of operations or cash flows.

ASU 2015-01

In January 2015, the FASB issued ASU 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20).” ASU 2015-01 simplifies income statement presentation by eliminating the concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015, with early adoption permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. The adoption of ASU 2015-01 will not have any effect on our financial position, results of operations or cash flows.

ASU 2014-12

In June 2014, the FASB issued ASU No. 2014-12, "Compensation - Stock Compensation (Topic 718)". ASU No. 2014-12 addresses accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. ASU 2014-12 indicates that, in such situations, the performance target should be treated as a performance condition and, accordingly, the performance target should not be reflected in estimating the grant-date fair value of the award. Instead, compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved. ASU 2014-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. We do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.

ASU 2014-09

In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers". ASU 2014-09 clarifies the principles for recognizing revenue and develops a common revenue standard for U.S. GAAP and the International Accounting Standards Board that:

• removes inconsistencies and weaknesses in revenue requirements;

• provides a more robust framework for addressing revenue issues;

• improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets;

• provides more useful information to users of financial statements through improved disclosure requirements; and

• simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer.

ASU 2014-09 is effective for annual and interim periods beginning on or after December 15, 2016. While we do not expect the adoption of ASU 2014-09 to have a material effect on our business, we are still evaluating any potential impact that adoption of

ASU 2014-09 may have on our financial position, results of operations or cash flows.

ASU 2014-08

In April 2014, the FASB issued ASU No. 2014-08, "Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity". ASU 2014-08 amends the definition for what types of asset disposals are to be considered discontinued operations, and amends the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 also enhances the convergence of the FASB’s and the International Accounting Standard Board’s reporting requirements for discontinued operations. ASU 2014-08 is effective for annual periods beginning on or after December 15, 2014, and interim periods within annual periods beginning on or after December 15, 2015. We do not expect the adoption of ASU 2014-08 to have a material effect on our financial position, results of operations or cash flows.

XML

Fair Value Measurements (Details) (Fair Value, Measurements, Recurring, USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	$ 13,904	$ 24,068
Available for Sale Securities	51,390	26,984
Assets measured at fair value	65,294	51,052
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	10,630	2,591
Available for Sale Securities	0	0
Assets measured at fair value	10,630	2,591
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	3,274	21,477
Available for Sale Securities	51,390	26,984
Assets measured at fair value	54,664	48,461
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Available for Sale Securities	0	0
Assets measured at fair value	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	10,630	2,591
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	10,630	2,591
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Money market funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	1,000	12,497
Available for Sale Securities	4,996
Commercial paper | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Available for Sale Securities	0
Commercial paper | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	1,000	12,497
Available for Sale Securities	4,996
Commercial paper | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Available for Sale Securities	0
Variable-rate demand notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	8,000
Variable-rate demand notes | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Variable-rate demand notes | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	8,000
Variable-rate demand notes | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	245	980
Available for Sale Securities	21,318	14,202
Certificates of deposit | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Available for Sale Securities	0	0
Certificates of deposit | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	245	980
Available for Sale Securities	21,318	14,202
Certificates of deposit | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0	0
Available for Sale Securities	0	0
Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	2,029
Available for Sale Securities	25,076	12,782
Corporate bonds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0
Available for Sale Securities	0	0
Corporate bonds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	2,029
Available for Sale Securities	25,076	12,782
Corporate bonds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	0
Available for Sale Securities	$ 0	$ 0

XML

Product Warranties (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Movement in Product Warranty Liability [Roll Forward]
Balance, beginning of period	$ 2,246	$ 1,638
Accruals	815	921
Payments	(564)	(576)
Balance, end of period	$ 2,497	$ 1,983
Minimum
Product Liability Contingency [Line Items]
Product warranty period	30 days

XML

Condensed Consolidated Balance Sheets (Unaudited) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 30,693	$ 45,206
Available-for-sale securities	51,390	26,984
Trade receivables, net of allowances of $36 and $108	16,816	26,260
Inventories	19,966	24,896
Prepaids and other current assets	5,342	6,987
Income taxes receivable	22	50
Deferred income tax assets	11,030	12,368
Total current assets	135,259	142,751
Property, plant and equipment, net	9,665	9,634
Goodwill	2,318	2,520
Other intangible assets, net	10,285	10,575
Long-term deferred income tax assets	4,797	9,546
Other assets	533	628
Total assets	162,857	175,654
Liabilities and Shareholders' Equity
Trade payables	26,829	47,574
Accrued liabilities	9,140	9,851
Warranty obligations, current portion	2,497	2,246
Total current liabilities	38,466	59,671
Income taxes payable, non-current	3,828	3,725
Other long-term liabilities	1,186	1,186
Total liabilities	43,480	64,582
Commitments and contingencies (Note 13)
Shareholders' equity:
Common stock - no par value, 75,000 shares authorized, 31,382 and 31,333 shares issued and outstanding	6,091	8,033
Retained earnings	114,079	103,347
Accumulated other comprehensive loss	(793)	(308)
Total shareholders' equity	119,377	111,072
Total liabilities and shareholders' equity	$ 162,857	$ 175,654

XML

Commitments and Contingencies (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Standby letters of credit outstanding	$ 0.6
Non-cancelable market-based purchase obligation	$ 20.5

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Unrealized loss on marketable securities, tax expense	$ 0	$ 0
Foreign currency translation, tax expense	$ 5	$ 5

XML

Goodwill and Other Intangible Assets Goodwill Roll Forward (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Goodwill [Roll Forward]
Balance	$ 2,520	$ 2,740
Currency exchange rate adjustment	(202)	(220)
Balance	$ 2,318	$ 2,520

XML

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2015

Fair Value Disclosures [Abstract]

Assets measured at fair value on a recurring basis

Assets measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014 were as follows (in thousands):

	March 31, 2015
	Level 1		Level 2		Level 3		Total
Cash Equivalents
Money market funds	$	10,630	$	—	$	—	$	10,630
Certificates of deposit(1)	—		245		—		245
Commercial paper	—		1,000		—		1,000
Corporate bonds	—		2,029		—		2,029
Variable-rate demand notes	—		—		—		—
Total Cash Equivalents	10,630		3,274		—		13,904
Available-for-Sale Securities
Certificates of deposit(1)	—		21,318		—		21,318
Commercial paper	—		4,996		—		4,996
Corporate bonds	—		25,076		—		25,076
Total Available-for-Sale Securities	—		51,390		—		51,390
Total assets measured at fair value	$	10,630	$	54,664	$	—	$	65,294

⁽¹⁾ All certificates of deposit are within current FDIC insurance limits.

	December 31, 2014
	Level 1		Level 2		Level 3		Total
Cash Equivalents
Money market funds	$	2,591	$	—	$	—	$	2,591
Certificates of deposit(1)	—		980		—		980
Commercial paper	—		12,497		—		12,497
Variable rate demand notes	—		8,000		—		8,000
Total Cash Equivalents	2,591		21,477		—		24,068
Available-for-Sale Securities
Certificates of deposit(1)	—		14,202		—		14,202
Corporate bonds	—		12,782		—		12,782
Total Available-for-Sale Securities	—		26,984		—		26,984
Total assets measured at fair value	$	2,591	$	48,461	$	—	$	51,052

⁽¹⁾ All certificates of deposit are within current FDIC insurance limits.

XML

Goodwill and Other Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Other intangible assets:
Indefinite-lived trademarks	9,052	$ 9,052
Patents	18,154	18,154
Total other intangible assets, gross	27,206	27,206
Accumulated amortization - patents	(16,921)	(16,631)
Other intangible assets, net	10,285	$ 10,575
Patents | Minimum
Other intangible assets:
Estimated Useful Life (in years)	8 years
Patents | Maximum
Other intangible assets:
Estimated Useful Life (in years)	16 years

XML

Property, Plant, and Equipment (Tables)

3 Months Ended

Mar. 31, 2015

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant and Equipment

Property, plant and equipment consisted of the following (in thousands):

	Estimated Useful Life (in years)			As of
				March 31, 2015			December 31, 2014
Automobiles	5			$	23		$	23
Leasehold improvements	5	to	20	2,159			2,144
Computer software and equipment	3	to	7	25,550			25,397
Machinery and equipment	3	to	5	6,724			6,709
Furniture and fixtures	5			1,104			1,108
Work in progress(1)	N/A			861			421
Total cost				36,421			35,802
Accumulated depreciation				(26,756		)	(26,168		)
Total property, plant and equipment, net				$	9,665		$	9,634

⁽¹⁾ Work in progress includes production tooling and internal use software development.

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Income from continuing operations	$ 10,859	$ 5,748
Loss from discontinued operations	(127)	(374)
Net income	10,732	5,374
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	910	865
Provision for (benefit from) allowance for doubtful accounts	(108)	30
Inventory lower-of-cost-or-market adjustments	18	589
Stock-based compensation expense	301	265
(Gain) loss on asset dispositions	(2)	1
Deferred income taxes, net of valuation allowance	6,102	2,321
Excess tax deficiency related to stock-based awards	2	102
Changes in operating assets and liabilities:
Trade receivables	9,719	11,752
Inventories	4,930	1,765
Prepaids and other current assets	1,763	2,617
Income taxes	27	356
Trade payables	(20,612)	(9,830)
Accrued liabilities, including warranty obligations	(298)	(1,085)
Net cash provided by operating activities	13,484	15,122
Cash flows from investing activities:
Purchases of available-for-sale securities	(30,440)	(13,518)
Proceeds from maturities of available-for-sale securities	3,680	0
Proceeds from sales of available-for-sale securities	2,354	0
Purchases of property, plant and equipment	(590)	(521)
Net cash used in investing activities	(24,996)	(14,039)
Cash flows from financing activities:
Proceeds from exercise of stock options	407	42
Payments for stock repurchases	(1,996)	0
Tax payments related to stock award issuances	(652)	0
Excess tax deficiency related to stock-based awards	(2)	(102)
Net cash used in financing activities	(2,243)	(60)
Effect of exchange rate changes on cash and cash equivalents	(758)	33
Increase (decrease) in cash and cash equivalents	(14,513)	1,056
Cash and cash equivalents:
Beginning of period	45,206	40,979
End of period	30,693	42,035
Supplemental disclosure of cash flow information:
Cash paid for interest	(6)	(7)
Cash paid for income taxes, net	(332)	(95)
Supplemental disclosure of non-cash investing activities:
Capital expenditures incurred but not yet paid	$ 64	$ 0

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Allowance for doubtful trade receivables	$ 36	$ 108
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	31,382,000	31,333,000
Common stock, shares outstanding	31,382,000	31,333,000

XML

Income Per Share

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Income Per Share

INCOME PER SHARE

Basic per share amounts were computed using the weighted average number of common shares outstanding. Diluted per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method. The weighted average numbers of shares outstanding used to compute income per share were as follows (in thousands):

	Three Months Ended March 31,
	2015	2014
Shares used to calculate basic income per share	31,396	31,172
Dilutive effect of outstanding stock options, performance stock units and restricted stock units	371	378
Shares used to calculate diluted income per share	31,767	31,550

The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted income per share because, in the case of stock options, the average market price did not exceed the exercise price, and for the performance stock units, because these shares are subject to performance conditions that had not been met. These shares may be dilutive potential common shares in the future (in thousands):

	Three Months Ended March 31,
	2015	2014
Stock options	25	320
Performance stock units	163	84

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	Apr. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	NAUTILUS, INC.
Entity Central Index Key	0001078207
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		31,382,889

XML

Stock Repurchase Program

3 Months Ended

Mar. 31, 2015

Stockholders' Equity Note [Abstract]

Stock Repurchase Program

STOCK REPURCHASE PROGRAM

On November 3, 2014, our Board of Directors approved a stock repurchase program that authorized us to repurchase up to $15.0 million of our outstanding common stock from time to time over a period of 24 months. The repurchase program expires November 3, 2016. Share repurchases will be funded with existing cash balances and repurchased shares will be retired and returned to unissued authorized shares. During the first quarter of 2015, we repurchased 133,877 shares at an average price of $14.91per share for a total of$2.0 million, and, as of March 31, 2015,$13.0 millionremains available for future repurchases.

For additional information, see Issuer Purchases of Equity Securitiesat Part II, Item 2, "Unregistered Sales of Equity Securities and Use of Proceeds" in this Form 10-Q.

XML

Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Net sales	$ 96,239	$ 71,903
Cost of sales	42,350	33,422
Gross profit	53,889	38,481
Operating expenses:
Selling and marketing	28,399	21,774
General and administrative	5,578	5,803
Research and development	2,307	1,903
Total operating expenses	36,284	29,480
Operating income	17,605	9,001
Other income (expense):
Interest income	44	8
Interest expense	(5)	(7)
Other, net	(116)	(61)
Total other income (expense), net	(77)	(60)
Income from continuing operations before income taxes	17,528	8,941
Income tax provision	6,669	3,193
Income from continuing operations	10,859	5,748
Discontinued operations:
Loss from discontinued operations before income taxes	(153)	(512)
Income tax benefit from discontinued operations	(26)	(138)
Loss from discontinued operations	(127)	(374)
Net income	$ 10,732	$ 5,374
Earnings Per Share, Basic [Abstract]
Basic income per share from continuing operations (in dollars per share)	$ 0.35	$ 0.18
Basic loss per share from discontinued operation (in dollars per share)	$ 0.00	$ (0.01)
Basic net income per share (in dollars per share)	$ 0.34	$ 0.17
Earnings Per Share, Diluted [Abstract]
Diluted income per share from continuing operations (in dollars per share)	$ 0.34	$ 0.18
Diluted loss per share from discontinued operation (in dollars per share)	$ 0.00	$ (0.01)
Diluted net income per share (in dollars per share)	$ 0.34	$ 0.17
Shares used in per share calculations:
Basic (in shares)	31,396	31,172
Diluted (in shares)	31,767	31,550

XML

Property, Plant and Equipment

3 Months Ended

Mar. 31, 2015

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following (in thousands):

	Estimated Useful Life (in years)			As of
				March 31, 2015			December 31, 2014
Automobiles	5			$	23		$	23
Leasehold improvements	5	to	20	2,159			2,144
Computer software and equipment	3	to	7	25,550			25,397
Machinery and equipment	3	to	5	6,724			6,709
Furniture and fixtures	5			1,104			1,108
Work in progress(1)	N/A			861			421
Total cost				36,421			35,802
Accumulated depreciation				(26,756		)	(26,168		)
Total property, plant and equipment, net				$	9,665		$	9,634

⁽¹⁾ Work in progress includes production tooling and internal use software development.

XML

Inventories

3 Months Ended

Mar. 31, 2015

Inventory Disclosure [Abstract]

Inventories

INVENTORIES

Inventories are stated at the lower of cost or market, with cost determined based on the first-in, first-out method. We establish inventory allowances for excess, slow-moving and obsolete inventory based on inventory levels, expected product life and forecasted sales. Inventories are written down to market value based on historical demand, competitive factors, changes in technology and product lifecycles.

Inventories consisted of the following (in thousands):

	As of
	March 31, 2015		December 31, 2014
Finished goods	$	18,660	$	23,765
Parts and components	1,306		1,131
Total inventories	$	19,966	$	24,896

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2015

Inventory Disclosure [Abstract]

Schedule of Inventories, Net of Valuation Allowances

Inventories consisted of the following (in thousands):

	As of
	March 31, 2015		December 31, 2014
Finished goods	$	18,660	$	23,765
Parts and components	1,306		1,131
Total inventories	$	19,966	$	24,896

XML

Segment and Enterprise-wide Information

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment and Enterprise-wide Information

SEGMENT AND ENTERPRISE-WIDE INFORMATION

We have two reportable segments - Direct and Retail. Contribution is the measure of profit or loss, defined as Net Sales less product costs and directly attributable expenses. Directly attributable expenses include Selling and Marketing expenses, General and Administrative expenses, and Research and Development expenses that are directly related to segment operations. Segment assets are those directly assigned to an operating segment's operations, primarily Accounts Receivable, Inventories, Goodwill and Other Intangible Assets. Unallocated assets primarily include Cash and Cash Equivalents, Available-for-Sale Securities, Prepaids and Other Current Assets, Deferred Income Tax Assets, Other Assets, shared information technology infrastructure, distribution centers and corporate headquarters. Capital expenditures directly attributable to the Direct and Retail segments were not significant in either period presented.

Following is summary information by reportable segment (in thousands):

	Three Months Ended March 31,
	2015			2014
Net sales:
Direct	$	74,057		$	50,735
Retail	21,290			20,103
Unallocated royalty income	892			1,065
Consolidated net sales	$	96,239		$	71,903
Contribution:
Direct	$	19,571		$	10,352
Retail	1,500			2,509
Unallocated royalty income	892			1,065
Consolidated contribution	$	21,963		$	13,926
Reconciliation of consolidated contribution to income from continuing operations:
Consolidated contribution	$	21,963		$	13,926
Amounts not directly related to segments:
Operating expenses	(4,358		)	(4,925		)
Other expense, net	(77		)	(60		)
Income tax expense	(6,669		)	(3,193		)
Income from continuing operations	$	10,859		$	5,748

There was no material change in the allocation of assets by segment during the first three months of 2015 and, accordingly, assets by segment are not presented.

For the three months ended March 31, 2015 and 2014, no customer represented 10.0% or more of total Net Sales.

XML

Product Warranties

3 Months Ended

Mar. 31, 2015

Product Warranties Disclosures [Abstract]

Product Warranties

PRODUCT WARRANTIES

Our products carry limited, defined warranties for defects in materials or workmanship which, according to their terms, generally obligate us to pay the costs of supplying and shipping replacement parts to customers and, in certain instances, pay for labor and other costs to service products. Outstanding product warranty periods range from thirty days to, in limited circumstances, the lifetime of certain product components. We record a liability at the time of sale for the estimated costs of fulfilling future warranty claims. If necessary, we adjust the liability for specific warranty-related matters when they become known and are reasonably estimable. Estimated warranty expense is included in Cost of Sales, based on historical warranty claim experience and available product quality data. Warranty expense is affected by the performance of new products, significant manufacturing or design defects not discovered until after the product is delivered to the customer, product failure rates, and higher or lower than expected repair costs. If warranty expense differs from previous estimates, or if circumstances change such that the assumptions inherent in previous estimates are no longer valid, the amount of product warranty obligations is adjusted accordingly.

Changes in our product warranty obligations were as follows (in thousands):

	Three Months Ended March 31,
	2015			2014
Balance, beginning of period	$	2,246		$	1,638
Accruals	815			921
Payments	(564		)	(576		)
Balance, end of period	$	2,497		$	1,983

XML

Goodwill and Other Intangible Assets

3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

All goodwill is assigned to our Direct reporting segment. The rollforward of goodwill was as follows (in thousands):

Balance, January 1, 2014	$	2,740
Currency exchange rate adjustment	(220		)
Balance, December 31, 2014	2,520
Currency exchange rate adjustment	(202		)
Balance, March 31, 2015	$	2,318

Other Intangible Assets

Other intangible assets consisted of the following (in thousands):

	Estimated Useful Life (in years)			As of
				March 31, 2015			December 31, 2014
Other intangible assets:
Indefinite-lived trademarks	N/A			$	9,052		$	9,052
Patents	8	to	16	18,154			18,154
				27,206			27,206
Accumulated amortization - patents				(16,921		)	(16,631		)
Other intangible assets, net				$	10,285		$	10,575

Amortization expense was as follows (in thousands):

	Three Months Ended March 31,
	2015		2014
Patent amortization	$	290	$	510

Future amortization of patents is as follows (in thousands):

Remainder of 2015	$	538
2016	430
2017	143
2018	65
2019	35
Thereafter	22
	$	1,233

XML

Accrued Liabilities

3 Months Ended

Mar. 31, 2015

Payables and Accruals [Abstract]

Accrued Liabilities

ACCRUED LIABILITIES

Accrued liabilities consisted of the following (in thousands):

	As of
	March 31, 2015		December 31, 2014
Payroll and related liabilities	$	3,632	$	5,058
Other	5,508		4,793
Total accrued liabilities	$	9,140	$	9,851

XML

Accumulated Other Comprehensive Income (Loss)

3 Months Ended

Mar. 31, 2015

Equity [Abstract]

Accumulated Other Comprehensive Income (Loss)

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Accumulated other comprehensive income (loss), net of applicable taxes, reported on our Condensed Consolidated Balance Sheets consists of unrealized holding losses on available-for-sale securities and foreign currency translation adjustments. The following tables set forth the changes in accumulated other comprehensive income (loss), net of tax (in thousands):

	Unrealized Loss on Available-for-Sale Securities			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Loss
Balance, December 31, 2014	$	(18	)	$	(290	)	$	(308	)
Current period other comprehensive loss	(1		)	(484		)	(485		)
Balance, March 31, 2015	$	(19	)	$	(774	)	$	(793	)

	Unrealized Loss on Available-for-Sale Securities			Foreign Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2013	$	—		$	244		$	244
Current period other comprehensive loss	(13		)	(164		)	(177		)
Balance, March 31, 2014	$	(13	)	$	80		$	67

XML

Property, Plant and Equipment (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 36,421	$ 35,802
Accumulated depreciation	(26,756)	(26,168)
Total property, plant and equipment, net	9,665	9,634
Automobiles
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	23	23
Estimated Useful Life (in years)	5 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	2,159	2,144
Leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	5 years
Leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	20 years
Computer software and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	25,550	25,397
Computer software and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	3 years
Computer software and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	7 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	6,724	6,709
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	5 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	1,104	1,108
Estimated Useful Life (in years)	5 years
Work in Progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 861	$ 421

XML

Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2015

Discontinued Operations and Disposal Groups [Abstract]

Schedule of liabilities for exit costs related to discontinued operations

The following table summarizes liabilities for exit costs related to discontinued operations, included in Accrued Liabilities and Other Long-Term Liabilities in our Condensed Consolidated Balance Sheets (in thousands):

	Facilities Leases
Balance, December 31, 2014	$	573
Adjustments	—
Payments	(67		)
Balance, March 31, 2015	$	506

XML

Accrued Liabilities (Tables)

3 Months Ended

Mar. 31, 2015

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

	As of
	March 31, 2015		December 31, 2014
Payroll and related liabilities	$	3,632	$	5,058
Other	5,508		4,793
Total accrued liabilities	$	9,140	$	9,851

XML

Accumulated Other Comprehensive Income (Loss) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	$ (308)	$ 244
Current period other comprehensive loss	(485)	(177)
Balance at end of period	(793)	67
Unrealized Loss on Available-for-Sale Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	(18)	0
Current period other comprehensive loss	(1)	(13)
Balance at end of period	(19)	(13)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	(290)	244
Current period other comprehensive loss	(484)	(164)
Balance at end of period	$ (774)	$ 80

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Net income	$ 10,732	$ 5,374
Other comprehensive loss:
Unrealized loss on marketable securities, net of income tax expense of $0 and $0	(1)	(13)
Foreign currency translation, net of income tax expense of $5 and $5	(484)	(164)
Comprehensive income	$ 10,247	$ 5,197

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2015

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

Factors used in determining the fair value of financial assets and liabilities are summarized into three broad categories:

• Level 1 - observable inputs such as quoted prices (unadjusted) in active liquid markets for identical securities as of the reporting date;

• Level 2 - other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk; or observable market prices in markets with insufficient volume and/or infrequent transactions; and

• Level 3 - significant inputs that are generally unobservable inputs for which there is little or no market data available, including our own assumptions in determining fair value.

Assets measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014 were as follows (in thousands):

	March 31, 2015
	Level 1		Level 2		Level 3		Total
Cash Equivalents
Money market funds	$	10,630	$	—	$	—	$	10,630
Certificates of deposit(1)	—		245		—		245
Commercial paper	—		1,000		—		1,000
Corporate bonds	—		2,029		—		2,029
Variable-rate demand notes	—		—		—		—
Total Cash Equivalents	10,630		3,274		—		13,904
Available-for-Sale Securities
Certificates of deposit(1)	—		21,318		—		21,318
Commercial paper	—		4,996		—		4,996
Corporate bonds	—		25,076		—		25,076
Total Available-for-Sale Securities	—		51,390		—		51,390
Total assets measured at fair value	$	10,630	$	54,664	$	—	$	65,294

⁽¹⁾ All certificates of deposit are within current FDIC insurance limits.

	December 31, 2014
	Level 1		Level 2		Level 3		Total
Cash Equivalents
Money market funds	$	2,591	$	—	$	—	$	2,591
Certificates of deposit(1)	—		980		—		980
Commercial paper	—		12,497		—		12,497
Variable rate demand notes	—		8,000		—		8,000
Total Cash Equivalents	2,591		21,477		—		24,068
Available-for-Sale Securities
Certificates of deposit(1)	—		14,202		—		14,202
Corporate bonds	—		12,782		—		12,782
Total Available-for-Sale Securities	—		26,984		—		26,984
Total assets measured at fair value	$	2,591	$	48,461	$	—	$	51,052

⁽¹⁾ All certificates of deposit are within current FDIC insurance limits.

We did not have any liabilities measured at fair value on a recurring basis as of March 31, 2015 or December 31, 2014.

We recognize transfers between levels at the actual date of the event or change in circumstance that caused the transfer.  There were no transfers between levels during the three months ended March 31, 2015, nor for the year ended December 31, 2014.

We did not have any changes to our valuation techniques during the three months ended March 31, 2015.

We classify our marketable securities as available-for-sale and, accordingly, record them at fair value. Level 1 investments valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 investments valuations are obtained from inputs, other than quoted market prices in active markets, that are directly or indirectly observable in the marketplace and quoted prices in markets with limited volume or infrequent transactions. The factors or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. Unrealized holding gains and losses are excluded from earnings and are reported net of tax in Comprehensive Income until realized.

We recognize or disclose the fair value of certain assets, such as non-financial assets, primarily Property, Plant and Equipment, Goodwill, Other Intangible Assets and certain other long-lived assets in connection with impairment evaluations. All of our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy. We did not perform any valuations on assets or liabilities that are valued at fair value on a nonrecurring basis during the first quarter of 2015. During the fourth quarter of 2014, we performed our annual Goodwill and indefinite-lived trade names impairment valuations effective as of October 1, 2014. During the three months ended March 31, 2015 and the year ended December 31, 2014, we did not record any other-than-temporary impairments on our financial assets required to be measured at fair value on a nonrecurring basis.

XML

Product Warranties (Tables)

3 Months Ended

Mar. 31, 2015

Product Warranties Disclosures [Abstract]

Schedule of Product Warranty Liability

Changes in our product warranty obligations were as follows (in thousands):

	Three Months Ended March 31,
	2015			2014
Balance, beginning of period	$	2,246		$	1,638
Accruals	815			921
Payments	(564		)	(576		)
Balance, end of period	$	2,497		$	1,983

XML

Goodwill and Other Intangible Assets Future intangible amortization (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2015	$ 538
2016	430
2017	143
2018	65
2019	35
Thereafter	22
Finite-Lived Intangible Assets, Net	$ 1,233

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

Guarantees, Commitments and Off-Balance Sheet Arrangements

As of March 31, 2015, we had approximately $0.6 million in standby letters of credit with certain vendors with expiration dates through April 2016.

We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of March 31, 2015, we had approximately $20.5 million in noncancelable market-based purchase obligations, primarily for inventory purchases expected to be received within the next twelve months. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses.

In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

The nature and terms of these indemnification obligations vary from contract to contract, and generally a maximum obligation is not stated within the agreements. We hold insurance policies that mitigate potential losses arising from certain types of indemnification obligations. Management does not deem these obligations to be significant to our financial position, results of operations or cash flows and, therefore, no related liabilities were recorded as of March 31, 2015.

Legal Matters

In 2004, we were sued in the Southern District of New York by BioSig Instruments, Inc. for alleged patent infringement in connection with our incorporation of heart rate monitors into certain cardio products. No significant activity in the litigation occurred until 2008. In 2012, the United States District Court granted summary judgment to us on grounds that BioSig’s patents

were invalid as a matter of law. BioSig appealed the grant of summary judgment and, in April 2013, the United States Court of Appeals for the Federal Circuit reversed the District Court’s decision on summary judgment and remanded the case to the District Court for further proceedings. On January 10, 2014, the U.S. Supreme Court granted our petition for a writ of certiorari to address the legal standard applied by the Federal Circuit in determining whether the patents may be valid under applicable law. The case was argued before the Supreme Court on April 28, 2014. By decision dated June 2, 2014, the Supreme Court unanimously reversed the Federal Circuit, holding that its standard of when a patent may be “indefinite” was incorrect and remanding to the Federal Circuit for reconsideration under the correct standard. The remand hearing in the Federal Circuit was held on October 29, 2014. By decision dated April 27, 2015, the same panel of the Federal Circuit affirmed its earlier reversal of the District Court’s decision. Unless we elect to petition for a rehearing en banc in the Federal Circuit or for further review in the United States Supreme Court the case will be returned to the District Court for further proceedings. We are currently evaluating these procedural options. We do not believe that our use of heart rate monitors utilized or purchased from third parties, and otherwise, infringes the BioSig patents.

In August 2014, we initiated an arbitration proceeding under a 1999 license agreement pursuant to which we had licensed certain rights relating to our TreadClimber^® products. We believe that our obligation to pay royalties under the license agreement ceased in the fourth quarter of 2013. The licensor disputes this and issued a notice under the contract claiming breach of the license agreement and asserting various remedies. We are seeking a declaratory ruling in the arbitration that we have performed all of our obligations under the license agreement, and that there is no continuing obligation for us to pay royalties. The licensor has asserted various counterclaims in the arbitration, including contract and intellectual property claims, and asserted various remedies, including termination of the license agreement. We replied to the counterclaim, denying the allegations and demanding remedies and asserting defenses. The arbitration is being administered by the American Arbitration Association and is in its preliminary stages. An arbitrator has been selected, however, a stay of the arbitration proceedings has been issued.

In addition to the matters described above, from time to time, we may be involved in various claims, lawsuits and other proceedings. These legal and tax proceedings involve uncertainty as to the eventual outcomes and losses which may be realized when one or more future events occur or fail to occur.

Litigation and jury verdicts are, to some degree, inherently unpredictable, and, although we have determined that a loss is not probable in connection with any current legal proceeding, it is reasonably possible that a loss may be incurred in connection with proceedings to which we are a party. Assessment of whether incurrence of a loss is probable, or a reasonable possibility, in connection with a particular proceeding, and estimation of the loss, or a range of loss, involves complex judgments and numerous uncertainties. Management is unable to estimate a range of reasonably possible losses related to litigation in its early stages, especially when the damages sought are indeterminate, or the legal and factual basis for the relevant claims have not been developed with specificity. As such, zero liability is recorded as of March 31, 2015.

We regularly monitor our estimated exposure to these contingencies and, as additional information becomes known, may change our estimates accordingly. We evaluate, on a quarterly basis, developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would make a loss probable or reasonably possible, and whether the amount of a probable or reasonably possible loss is estimable. Among other factors, we evaluate the advice of internal and external counsel, the outcomes from similar litigation, current status of the lawsuits (including settlement initiatives), legislative developments and other factors. Due to the numerous variables associated with these judgments and assumptions, both the precision and reliability of the resulting estimates of the related loss contingencies are subject to substantial uncertainties.